cyproterone acetate has been researched along with minoxidil in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 3 (25.00) | 18.2507 |
2000's | 5 (41.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Vermorken, AJ | 1 |
Callan, AW; Montalto, J | 1 |
Price, VH; Shapiro, J | 1 |
Sinclair, RD; Tran, D | 1 |
Boudou, P; Chaspoux, C; Fiet, J; Hardy, N; Jouanique, C; Reygagne, P; Vexiau, P | 1 |
Hannuksela, M | 1 |
Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA | 1 |
Scheinfeld, N | 1 |
Dickson, GM | 1 |
Ioannides, D; Lazaridou, E | 1 |
6 review(s) available for cyproterone acetate and minoxidil
Article | Year |
---|---|
Female androgenetic alopecia: an update.
Topics: Alopecia; Androgens; Cyproterone Acetate; Female; Humans; Minoxidil; Prognosis; Spironolactone | 1995 |
Hair regrowth. Therapeutic agents.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone | 1998 |
Understanding and managing common baldness.
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome | 1999 |
[Loss of hair].
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome | 2000 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
1 trial(s) available for cyproterone acetate and minoxidil
Article | Year |
---|---|
Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial.
Topics: Administration, Topical; Adult; Alopecia; Androgen Antagonists; Body Mass Index; Contraceptives, Oral, Combined; Cyproterone Acetate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Minoxidil | 2002 |
5 other study(ies) available for cyproterone acetate and minoxidil
Article | Year |
---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Reversal of androgenic alopecia by minoxidil: lack of effect of simultaneously administered intermediate doses of cyproterone acetate.
Topics: Adult; Alopecia; Androgen Antagonists; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Humans; Male; Minoxidil; Pyrimidines | 1983 |
Evaluation and treatment of male and female pattern hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone | 2005 |
Menopause management: how you can do better.
Topics: Acupuncture Therapy; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Topical; Affect; Age Factors; Androgen Antagonists; Androgens; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atrophic Vaginitis; Azabicyclo Compounds; Bupropion; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Dyspareunia; Estrogens; Eszopiclone; Exercise; Female; Hair; Hormone Replacement Therapy; Hot Flashes; Humans; Hypnotics and Sedatives; Libido; Life Style; Lubricants; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Minoxidil; Phytotherapy; Piperazines; Sleep Initiation and Maintenance Disorders; Spironolactone; Testosterone | 2012 |